202 related articles for article (PubMed ID: 33212461)
21. Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C.
Shakoor A; Shafqat F; Mehmud Te; Akram M; Riaz S; Iqbal Z; Khan AA
J Ayub Med Coll Abbottabad; 2010; 22(4):6-9. PubMed ID: 22455250
[TBL] [Abstract][Full Text] [Related]
22. Immune response in addicts with chronic hepatitis C treated with interferon and ribavirin.
Sergio N; Salvatore T; Gaetano B; Davide P; Claudio I; Massimo L; Barbara M; Giuseppe A; Stefano C; Danila C; Aikaterini T; Luca I; Daniela C; Luciano C
J Gastroenterol Hepatol; 2007 Jan; 22(1):74-9. PubMed ID: 17201885
[TBL] [Abstract][Full Text] [Related]
23. High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
Waizmann M; Ackermann G
J Subst Abuse Treat; 2010 Jun; 38(4):338-45. PubMed ID: 20362408
[TBL] [Abstract][Full Text] [Related]
24. [Hepatitis C viral infection and depression].
Lengyel G; Aszalós Z; Tulassay Z
Orv Hetil; 2007 Jan; 148(1):11-5. PubMed ID: 17344112
[TBL] [Abstract][Full Text] [Related]
25. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
26. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
[TBL] [Abstract][Full Text] [Related]
27. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.
Kraus MR; Schäfer A; Csef H; Scheurlen M
World J Gastroenterol; 2005 Mar; 11(12):1769-74. PubMed ID: 15793861
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness and complications of combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C].
Hwang SY; Lee HJ; Park KT; Kim KY; Lee SM; Park CW; Kim TO; Kim GH; Heo J; Kang DH; Song GA; Cho M; Cho BM
Korean J Gastroenterol; 2007 Mar; 49(3):166-72. PubMed ID: 18172345
[TBL] [Abstract][Full Text] [Related]
29. [Why is there a poor response to combined therapy with interferon alfa 2b and ribavirin in patients with chronic hepatitis C?].
Stránský J; Rýzlová M; Stríteský J; Nĕmecek V
Cas Lek Cesk; 2002 Jun; 141(11):351-4. PubMed ID: 12099059
[TBL] [Abstract][Full Text] [Related]
30. Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.
Posthouwer D; Fischer K; De Heusden N; Mauser-Bunschoten EP
Haemophilia; 2007 Jan; 13(1):98-103. PubMed ID: 17212733
[TBL] [Abstract][Full Text] [Related]
31. [Serious side-effects of interferon alfa and ribavirin combination therapy in patients with chronic hepatitis C].
Stránský J; Skrivánková J
Vnitr Lek; 2002 Jan; 48(1):56-9. PubMed ID: 11852590
[TBL] [Abstract][Full Text] [Related]
32. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
[TBL] [Abstract][Full Text] [Related]
33. Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use.
Verrando R; Robaeys G; Matheï C; Buntinx F
Acta Gastroenterol Belg; 2005; 68(1):81-5. PubMed ID: 15832591
[TBL] [Abstract][Full Text] [Related]
34. Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.
Fontana RJ; Bieliauskas LA; Lindsay KL; Back-Madruga C; Wright EC; Snow KK; Lok AS; Kronfol Z; Padmanabhan L;
Hepatology; 2007 May; 45(5):1154-63. PubMed ID: 17465000
[TBL] [Abstract][Full Text] [Related]
35. [A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin].
Kim YH; Han WS; Lee SJ; Oh SN; Choi DW; Byun KS; Yeon JE
Korean J Hepatol; 2007 Sep; 13(3):419-22. PubMed ID: 17898559
[TBL] [Abstract][Full Text] [Related]
36. Serotonin gene polymorphisms and lifetime mood disorders in predicting interferon-induced depression in chronic hepatitis C.
Cozzolongo R; Porcelli P; Cariola F; Giannuzzi V; Lanzilotta E; Gentile M; Sonnante G; Leandro G
J Affect Disord; 2015 Sep; 183():90-7. PubMed ID: 26001668
[TBL] [Abstract][Full Text] [Related]
37. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
[TBL] [Abstract][Full Text] [Related]
38. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
Neri S; Pulvirenti D; Bertino G
Clin Drug Investig; 2006; 26(11):655-62. PubMed ID: 17163300
[TBL] [Abstract][Full Text] [Related]
39. Taste disturbances during therapy with pegylated interferon-alpha 2b and ribavirin in patients with chronic hepatitis C.
Klimacka-Nawrot E; Musialik J; Suchecka W; Petelenz M; Hartman M; Lichtański P; Błońska-Fajfrowska B
Wiad Lek; 2010; 63(4):289-99. PubMed ID: 21608370
[TBL] [Abstract][Full Text] [Related]
40. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
